22 Nov, 2024 Gene therapies and regulatory milestone triggers: Licensors and Licensees beware By Ellen Lambrix Luca Cericola As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...
19 Nov, 2024 Reasons to be cheerful: 4 takeaways from the BIA UK Life Sciences Regulatory Conference 2024 By Hugo Kent-Egan We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...
30 Oct, 2024 The first naked anti-TROP2 antibody progresses to a Phase 1/2a clinical trial By Matthew Warren Luca Cericola James Johnston On 24 October 2024, Cancer Research UK ("CRUK") and KisoJi Biotechnology Inc. ("KBI") announced that they have entered into an agreement...
28 Oct, 2024 Split poly(A) tail mRNA patents invalid for insufficiency and obviousness By Kate O'Sullivan This article was first published in Kluwer Patent Blog [October 2024]. On 8 October 2024, Mr Justice Meade handed down judgment in...
23 Sep, 2024 2024 ABPI Code of Practice launched - orange is the new blue By Jamie Hatzel The ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) have announced the release of the latest edition of the ABPI...
19 Aug, 2024 CASGEVY: CRISPR/Cas9 gene therapy now available in England following NICE recommendation By Claire Smith Luca Cericola Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...
10 Jul, 2024 Challenges and opportunities for bio innovation: Views from the ON Helix 2024 conference By Adam Coughlin Luca Cericola Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...
25 Jun, 2024 Biotech Review of the Year: Six months on By Bristows LLP It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...
13 Jun, 2024 Takeaways from the EU Pharma Law Forum 2024 By Jamie Hatzel Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...
11 Jun, 2024 Deal-making for cell and gene therapy companies: Insights from One Nucleus’ panel event By Claire Smith Luca Cericola Cell and gene therapies (CGTs) continue to hold considerable promise for the future of medicine, providing unprecedented therapeutic...
28 Mar, 2024 Publication - Patents: Review of the Year By Dominic Adair Katie Cambrook Brian Cordery Chloe Dickson Charlie French Matthew Hunt Nicholas Round Jonathan Ross Eden Winlow +6 more... Show less For patent practitioners everywhere, 2023 was a significant year. Ten years after the signing of the international treaty governing its...
25 Mar, 2024 A detailed analysis of the first substantive UPC Court of Appeal decision – lifting a preliminary injunction against NanoString By Eden Winlow NanoString Technologies Inc.; NanoString Technologies Germany GmbH; NanoString Technologies Netherlands B.V. v President and Fellows of...